Table 5

Transplantation-related toxicity and mortality comparison

ReferenceNo. of patients in studyDeaths, n (%)Stomatitis, n (%)Gut, n (%)Hepatic, n (%)Pulmonary, n (%)Cardiac, n (%)Renal, n (%)1-year NRM, %
Giralt (2001)16  78 3 (4) 5 (6) 5 (6) 2 (3) 7 (9) 44.7* 
Giralt (2002)49  22 1 (5) 1 (5) 1 (5) 1 (5) 1 (5) 40 ± 10 
Ritchie (2003)45  39 4 (10) 2 (5) 2 (5) 4 (10) 1 (3) 3 (8) 30 ± 7 
de Lima (2004)44  62 6 (10) 1 (2) 4 (6) 1 (2) 9 (14) 4 (6) 3 (5) 30 
Current study 33 3 (10) 1 (3) 5 (15) 1 (3) 3 (10) 19 ± 7 
ReferenceNo. of patients in studyDeaths, n (%)Stomatitis, n (%)Gut, n (%)Hepatic, n (%)Pulmonary, n (%)Cardiac, n (%)Renal, n (%)1-year NRM, %
Giralt (2001)16  78 3 (4) 5 (6) 5 (6) 2 (3) 7 (9) 44.7* 
Giralt (2002)49  22 1 (5) 1 (5) 1 (5) 1 (5) 1 (5) 40 ± 10 
Ritchie (2003)45  39 4 (10) 2 (5) 2 (5) 4 (10) 1 (3) 3 (8) 30 ± 7 
de Lima (2004)44  62 6 (10) 1 (2) 4 (6) 1 (2) 9 (14) 4 (6) 3 (5) 30 
Current study 33 3 (10) 1 (3) 5 (15) 1 (3) 3 (10) 19 ± 7 

All toxicities listed use the Bearman scale27  and show grade III and IV (lethal) toxicities before day 100. Studies listed used FLU/MEL conditioning regimens. n = number of events of each toxicity; and % = n divided by the number of patients on the study multiplied by 100.

*

For Giralt (2001),16  NRM not given at 1 year. At 2 years, 44.7%; at 100 days, 37.4%.

or Create an Account

Close Modal
Close Modal